Yüklüyor......
Adaptive Budgets in Clinical Trials
We consider situations where a drug developer gets access to additional financial resources when a promising result has been observed in a pre-planned interim analysis during a clinical trial which should lead to the registration of the drug. First the option that the drug developer completely puts...
Kaydedildi:
| Yayımlandı: | Stat Biopharm Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6485463/ https://ncbi.nlm.nih.gov/pubmed/31031887 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19466315.2013.783504 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|